Enveric Biosciences Inc. (ENVB)
NASDAQ: ENVB
· Real-Time Price · USD
1.09
-0.02 (-1.80%)
At close: Aug 15, 2025, 1:13 PM
-1.80% (1D)
| Bid | 1.08 |
| Market Cap | 2.69M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -9.3M |
| EPS (ttm) | -11.05 |
| PE Ratio (ttm) | -0.1 |
| Forward PE | -0.04 |
| Analyst | Buy |
| Ask | 1.12 |
| Volume | 27,617 |
| Avg. Volume (20D) | 259,646 |
| Open | 1.11 |
| Previous Close | 1.11 |
| Day's Range | 1.08 - 1.11 |
| 52-Week Range | 1.01 - 134.32 |
| Beta | 0.37 |
About ENVB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ENVB
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ENVB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts5 months ago
+94.92%
Enveric Biosciences shares are trading higher afte...
Unlock content with
Pro Subscription
5 months ago
-13.87%
Enveric Biosciences shares are trading higher after the company announced its non-hallucinogenic psychedelic compounds showed promise for treating addiction and ADHD.
23 hours ago · businesswire.com
Enveric Biosciences Reports Second Quarter 2025 Financial and Corporate ResultsCAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychi...
